Approval · Notice of Compliance 37236 · 2026
CAMCEVI: Notice of Compliance 37236
Issued March 31, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37236
- Date
- March 31, 2026
- Company
- Accord Healthcare IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CAMCEVI | 02567148 | Approved |
Medicinal ingredients
- LEUPROLIDE MESYLATE 21 MG per SYR